Cresco Labs (CRLBF) Short-term Investments (2019 - 2026)
Cresco Labs (CRLBF) posted Short-term Investments of $31.2 million for Q1 2026, down 5.89% on a QoQ basis from $33.2 million in Q4 2025, and up 788.93% year-over-year from $3.5 million in Q1 2025.
Cresco Labs (CRLBF) Short-term Investments (2019 - 2026) Analysis & Trends
Cresco Labs' Short-term Investments history runs 8 years deep, the most recent figure standing at $31.2 million for Q1 2026.
- Quarterly Short-term Investments rose 788.93% year-over-year to $31.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.2 million (up 788.93% YoY) and the FY2025 annual result came in at $33.2 million, up 864.93% from the prior year.
- Short-term Investments was $31.2 million for Q1 2026 at Cresco Labs, down from $33.2 million in the prior quarter.
- Across five years, Short-term Investments topped out at $33.3 million in Q3 2025 and bottomed at $1.7 million in Q1 2024.
- A 5-year average of $11.3 million and a median of $3.5 million in 2025 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2024 — Short-term Investments plunged 32.45% — and 2025, when it soared 921.23%.
- Cresco Labs' Short-term Investments stood at $2.6 million in 2022, then soared by 95.81% to $5.1 million in 2023, then sank by 32.45% to $3.4 million in 2024, then soared by 864.93% to $33.2 million in 2025, then decreased by 5.89% to $31.2 million in 2026.
- Business Quant data shows CRLBF's Short-term Investments at $31.2 million in Q1 2026, $33.2 million in Q4 2025, and $33.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.23 Mn |
| Dec 31, 2025 | 33.18 Mn |
| Sep 30, 2025 | 33.29 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 3.26 Mn |
| Jun 30, 2024 | 3.65 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Dec 31, 2023 | 5.09 Mn |
| Mar 31, 2022 | 2.60 Mn |
| Dec 31, 2021 | 2.56 Mn |
| Sep 30, 2021 | 1.96 Mn |
| Mar 31, 2021 | 3.47 Mn |
| Dec 31, 2020 | 4.44 Mn |
| Dec 31, 2019 | 1.15 Bn |